Xillix Announces Intent to Apply for Appointment of an Interim Receiver

    RICHMOND, BC, April 2 /CNW/ - Xillix Technologies Corp. (TSX: XLX) today
announced that following the death last week of Brett Gannon, President and
Chief Executive Officer, the board of directors has decided to apply to Court
for the appointment of an interim receiver. It is expected that this
application will be heard later this week or early next.
    The Company is subject to an order of the Court which provides protection
under the Companies' Creditors Arrangement Act (the "CCAA"). The appointment
of an interim receiver will provide the Company with an opportunity to
continue to develop and implement a reorganization plan under the CCAA.

    About Xillix
    Xillix Technologies Corp. is a Canadian medical device company and the
world leader in fluorescence endoscopy for improved cancer detection. Xillix's
currently approved device, Onco-LIFE(TM), incorporates fluorescence and
white-light endoscopy in a single device that has been developed for the
detection and localization of lung and gastrointestinal (GI) cancers. An
international multicenter lung cancer clinical trial of Onco-LIFE demonstrated
a 325% per- lesion improvement in the detection of early lung cancer
(moderate-severe dysplasia and carcinoma in situ) and a 250% per-patient
improvement compared to white-light alone. Onco-LIFE is approved for sale in
the United States for the lung application and in Europe, Canada and Australia
for both lung and GI applications. The Company also recently announced that it
has developed a new product, LIFE Luminus(TM), designed to allow fluorescence
imaging of the colon using conventional video endoscope technology.

    "Statements contained in this document which are not based on historical
fact, including without limitation, statements containing the words "may",
"will", "plans", "intends", "expects", "anticipates", "believes", "estimate",
"continue" and similar expressions, constitute "forward-looking information"
within the meaning of applicable Canadian securities laws. Forward-looking
statements contained in this document may involve, but are not limited to,
statements relating to the Company's objectives, priorities, strategies,
actions, targets, expectations and outlook. Forward-looking statements are
necessarily based upon assumptions and predictions with respect to the future,
including but not limited to the factors referred to below. As a result,
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results, events or
developments to be materially different from any future results, events or
developments expressed or implied thereby. These risks, uncertainties and
other factors include, but are not limited to the factors referred to in the
Company's Annual Information Form dated March 28, 2006 and its other filings
with the applicable Canadian securities regulatory authorities. In light of
these uncertainties, assumptions and risks, readers are cautioned not to place
undue reliance on such forward-looking statements, and the Company assumes no
obligation to update or revise such information to reflect later events or
developments, except as required by law."

    The Company is listed on the Toronto Stock Exchange under the trading
symbol "XLX".

For further information:

For further information: visit our website at http://www.xillix.com or
e-mail: ir@xillix.com

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890